Financhill
Buy
69

ABIT Quote, Financials, Valuation and Earnings

Last price:
$0.12
Seasonality move :
97.86%
Day range:
$0.11 - $0.12
52-week range:
$0.02 - $0.44
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
61.35x
Volume:
149.2K
Avg. volume:
591.5K
1-year change:
-30.12%
Market cap:
$486.4M
Revenue:
--
EPS (TTM):
--
Period Ending 2009-12-31 2010-12-31 2011-12-31 2012-12-31 2013-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $37.5K $119.7K $118.6K $109.9K $96.8K
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $37.5K $119.7K $118.6K $109.9K $96.8K
Operating Income -$37.5K -$119.7K -$118.6K -$109.9K -$96.8K
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$112.5K -$205K -$216.8K -$206.6K -$202.5K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$112.5K -$205K -$216.8K -$206.6K -$202.5K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$112.5K -$205K -$216.8K -$206.6K -$202.5K
 
Basic EPS (Cont. Ops) -$0.01 -$0.01 -$0.01 -$0.01 -$0.01
Diluted EPS (Cont. Ops) -$0.01 -$0.01 -$0.01 -$0.01 -$0.01
Weighted Average Basic Share $15.2M $15.2M $15.2M $15.2M $15.2M
Weighted Average Diluted Share $15.2M $15.2M $15.2M $15.2M $15.2M
 
EBITDA -$37.5K -$119.7K -$118.6K -$109.9K -$96.8K
EBIT -$37.5K -$119.7K -$118.6K -$109.9K -$96.8K
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$37.5K -$119.7K -$118.6K -$109.9K -$96.8K
Operating Income (Adjusted) -$37.5K -$119.7K -$118.6K -$109.9K -$96.8K
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Revenue -- -- -- $14M $65.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $11.4M $55.8M
Gross Profit -- -- -- $2.6M $9.8M
Gross Profit Margin -- -- -- 18.69% 14.98%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $1.3M $1.3M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- $1.5M $1.8M
Operating Income -- -- -- $1.1M $8M
 
Net Interest Expenses -- -- -- $164K $97K
EBT. Incl. Unusual Items -- -- -- $945K $7.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $807K $2M
Net Income to Company -- -- -- -$1.6M $8.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $138K $5.9M
 
Basic EPS (Cont. Ops) -- -- -- $0.00 $0.00
Diluted EPS (Cont. Ops) -- -- -- $0.00 $0.00
Weighted Average Basic Share -- -- -- $4.1B $4.1B
Weighted Average Diluted Share -- -- -- $4.3B $4.5B
 
EBITDA -- -- -- $1.1M $8M
EBIT -- -- -- $1.1M $8M
 
Revenue (Reported) -- -- -- $14M $65.6M
Operating Income (Reported) -- -- -- $1.1M $8M
Operating Income (Adjusted) -- -- -- $1.1M $8M
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- $164K $261K
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Revenue -- -- -- $14M $65.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $11.4M $55.8M
Gross Profit -- -- -- $2.6M $9.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $1.3M $1.3M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- $1.5M $1.8M
Operating Income -- -- -- $1.1M $8M
 
Net Interest Expenses -- -- -- $164K $97K
EBT. Incl. Unusual Items -- -- -- $945K $7.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $807K $2M
Net Income to Company -- -- -- -$1.6M $8.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $138K $5.9M
 
Basic EPS (Cont. Ops) -- -- -- $0.00 $0.00
Diluted EPS (Cont. Ops) -- -- -- $0.00 $0.00
Weighted Average Basic Share -- -- -- $4.1B $4.1B
Weighted Average Diluted Share -- -- -- $4.3B $4.5B
 
EBITDA -- -- -- $1.1M $8M
EBIT -- -- -- $1.1M $8M
 
Revenue (Reported) -- -- -- $14M $65.6M
Operating Income (Reported) -- -- -- $1.1M $8M
Operating Income (Adjusted) -- -- -- $1.1M $8M
Period Ending 2009-12-31 2010-12-31 2011-12-31 2012-12-31 2013-12-31
Cash and Equivalents $120 $30 $20 -- --
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $120 $30 $20 -- --
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $120 $30 $20 -- --
 
Accounts Payable $2K $1.7K $3.6K $3K $1.7K
Accrued Expenses $12.5K $12.5K $12.5K $12.5K $12.5K
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $14.5K $14.2K $16.1K $15.5K $1.4M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $949.9K $1.1M $1.2M $1.3M $1.4M
 
Common Stock $15.2K $1.5K $1.5K $15.2K $15.2K
Other Common Equity Adj -- -- -- -- --
Common Equity -$949.8K -$1.1M -$1.2M -$1.3M -$1.4M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$949.8K -$1.1M -$1.2M -$1.3M -$1.4M
 
Total Liabilities and Equity $120 $30 $20 -- --
Cash and Short Terms $120 $30 $20 -- --
Total Debt -- -- -- -- --
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Cash and Equivalents -- -- -- -- $13.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- $276K
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- $1.2M
Other Current Assets -- -- -- -- $29K
Total Current Assets -- -- -- -- $15.2M
 
Property Plant And Equipment -- -- -- -- $21.2M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- $321K
Total Assets -- -- -- -- $36.8M
 
Accounts Payable -- -- -- -- $2M
Accrued Expenses -- -- -- -- $248K
Current Portion Of Long-Term Debt -- -- -- -- $852K
Current Portion Of Capital Lease Obligations -- -- -- -- $5.4M
Other Current Liabilities -- -- -- -- $504K
Total Current Liabilities -- -- -- -- $15.1M
 
Long-Term Debt -- -- -- -- $3.2M
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- -- $28.9M
 
Common Stock -- -- -- -- $4.1M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -- $7.9M
 
Total Liabilities and Equity -- -- -- -- $36.8M
Cash and Short Terms -- -- -- -- $13.2M
Total Debt -- -- -- -- $8.1M
Period Ending 2009-12-31 2010-12-31 2011-12-31 2012-12-31 2013-12-31
Net Income to Stockholders -$112.5K -$205K -$216.8K -$206.6K -$202.5K
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $16K $95.8K $95.7K $95.8K $79.8K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$22.2K -$24.3K -$20.9K -$14.9K -$18.2K
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $22.2K $24.2K $20.9K -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $14.8K $18.2K
Cash From Financing $22.2K $24.2K $20.9K $14.8K $18.2K
 
Beginning Cash (CF) $130 $120 $30 $20 --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$10 -$90 -$10 -$20 --
Ending Cash (CF) $120 $30 $20 -- --
 
Levered Free Cash Flow -$22.2K -$24.3K -$20.9K -$14.9K -$18.2K
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Net Income to Stockholders -- -- -- -$1.6M $8.2M
Depreciation & Amoritzation -- -- -- $1.1M $1.6M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- $447K -$218K
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$5.1M -$10.1M
 
Capital Expenditures -- -- -- $603K $960K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- $5.7M $19.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -$523K $1.4M
 
Beginning Cash (CF) -- -- -- $4.8M $3.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $80K $10.5M
Ending Cash (CF) -- -- -- $4.9M $13.7M
 
Levered Free Cash Flow -- -- -- -$5.7M -$11M
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- $603K $1.6M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Net Income to Stockholders -- -- -- -$1.6M $8.2M
Depreciation & Amoritzation -- -- -- $1.1M $1.6M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- $447K -$218K
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$5.1M -$10.1M
 
Capital Expenditures -- -- -- $603K $960K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- $5.7M $19.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -$523K $1.4M
 
Beginning Cash (CF) -- -- -- $4.8M $3.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $80K $10.5M
Ending Cash (CF) -- -- -- $4.9M $13.7M
 
Levered Free Cash Flow -- -- -- -$5.7M -$11M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock